🌀 New tool Cochlea Simulator: explore the cochlea in 3D, from the travelling wave to implant stimulation. →🎧 New tool REM & RECD Workshop: measure what the device actually delivers in the ear. →🔧 New tool Device Technology Workshop: from WDRC to frequency lowering, what happens inside a hearing aid? →🎚 Simulator Audiometry Simulator: pure tones, masking and speech tests on a virtual patient. →🧩 Tool Device Selection Workshop: which device type and coupling suits which loss? →🩺 Guide Hearing & Balance Health Guide: from tinnitus to vertigo, A to Z. →🧠 Expert view In-depth pieces for clinicians, academics and graduate students. →📚 Glossary English–Turkish audiology terms, card by card. →📊 ODAK 82 assessment tools and scales in one place. →🎓 Audiology 101 Lecture notes, quizzes and case practice. →📝 New article AI tool CochleaNet assesses every neuron in the gene-treated cochlea one by one →🏛️ Congress notes BAA 2026 Liverpool: notes from the clinical audiology agenda →
Home / ODAK / European Evaluation of Vertigo (EEV)
Questionnaire/ScaleAdaptationOn request

European Evaluation of Vertigo (EEV)

Avrupa Vertigo Değerlendirme Ölçeği – Türkçe Versiyonu (EEV-TR)
Vestibular
Corresponding author: Başak Mutlu

Description

The EEV-TR is a five-item, clinician-rated scale assessing vertigo and imbalance symptoms over the previous week. Items cover the sensation of vertigo, its duration, discomfort from movement, nausea-vomiting and instability; each is scored 0–4, giving a total of 0–20, with higher scores indicating more severe symptoms. In the Turkish study (100 patients) Cronbach's α was 0.712 and 4-week test–retest ICC was 0.835; scores correlated significantly with the Vertigo Symptom Scale and discriminated BPPV at a moderate-to-high level.

At a Glance

RespondentClinician
Age groupAdult (18–64) · Older adult (65+)
Number of items5
Response formatClinician rating (0–4)
Total score0–20; higher = more severe symptoms
Internal consistencyα = 0.712 (baseline)
Test–retestICC = 0.835 (4 weeks)

Measured Properties

Sensation of dizziness, duration of dizziness, discomfort with movement, nausea-vomiting, imbalance

Target Population

Adults aged 18 and above with vestibular complaints

Source & Citation

MUTLU, B., MUTLU, A., & BAKICI, B. (2022). The Reliability and Validity of the Turkish Version of the European Evaluation of Vertigo Scale. Journal of Ear, Nose & Throat & Head & Neck Surgery, 30(3).
Go to source ↗

Original Scale

Original name: European Evaluation of Vertigo (EEV)

Megnigbeto, C. A., Sauvage, J. P., & Launois, R. (2001). The European Evaluation of Vertigo scale (EEV): a clinical validation study. Revue de Laryngologie Otologie Rhinologie, 122(2), 95-102.

Access

To access the full text of this tool, contacting the corresponding author is recommended.

Contact: basakogun@yahoo.com

Similar tools

← PreviousAmsterdam Inventory for Auditory Disability and Handicap (AIADH)Next →Decreased Sound Tolerance Scale–Screening (ASTÖ-T)